DE69722433D1 - Pharmazeutische zubereitungen, welche zidovudin und lamivudine enthalten - Google Patents

Pharmazeutische zubereitungen, welche zidovudin und lamivudine enthalten

Info

Publication number
DE69722433D1
DE69722433D1 DE69722433T DE69722433T DE69722433D1 DE 69722433 D1 DE69722433 D1 DE 69722433D1 DE 69722433 T DE69722433 T DE 69722433T DE 69722433 T DE69722433 T DE 69722433T DE 69722433 D1 DE69722433 D1 DE 69722433D1
Authority
DE
Germany
Prior art keywords
zidovudin
lamivudine
pharmaceutical preparations
preparations containing
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69722433T
Other languages
English (en)
Other versions
DE69722433T2 (de
Inventor
Wayne Goodson
Wayne Wood
Jeannette Ford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DE69722433D1 publication Critical patent/DE69722433D1/de
Publication of DE69722433T2 publication Critical patent/DE69722433T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DE69722433T 1996-10-31 1997-10-29 Pharmazeutische zubereitungen, welche zidovudin und lamivudine enthalten Expired - Lifetime DE69722433T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9622681 1996-10-31
GBGB9622681.6A GB9622681D0 (en) 1996-10-31 1996-10-31 Pharmaceutical compositions
PCT/EP1997/005953 WO1998018477A2 (en) 1996-10-31 1997-10-29 Pharmaceutical compositions containing lamivudine and zidovudine

Publications (2)

Publication Number Publication Date
DE69722433D1 true DE69722433D1 (de) 2003-07-03
DE69722433T2 DE69722433T2 (de) 2004-04-08

Family

ID=10802224

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69722433T Expired - Lifetime DE69722433T2 (de) 1996-10-31 1997-10-29 Pharmazeutische zubereitungen, welche zidovudin und lamivudine enthalten

Country Status (44)

Country Link
EP (1) EP0941100B1 (de)
JP (1) JP2001502718A (de)
KR (1) KR100551652B1 (de)
AP (1) AP1067A (de)
AR (1) AR009135A1 (de)
AT (1) ATE241364T1 (de)
AU (1) AU736607B2 (de)
BG (1) BG64541B1 (de)
BR (1) BR9712614A (de)
CA (1) CA2270174A1 (de)
CO (1) CO4930269A1 (de)
CY (1) CY2485B1 (de)
CZ (1) CZ296080B6 (de)
DE (1) DE69722433T2 (de)
DK (1) DK0941100T3 (de)
EA (1) EA002437B1 (de)
EE (1) EE03806B1 (de)
ES (1) ES2200204T3 (de)
GB (1) GB9622681D0 (de)
GE (1) GEP20022735B (de)
GT (1) GT199700116A (de)
HK (1) HK1020880A1 (de)
HR (1) HRP970569B1 (de)
HU (1) HU224969B1 (de)
ID (1) ID18698A (de)
IL (1) IL129422A0 (de)
IS (1) IS5024A (de)
MY (1) MY119513A (de)
NO (1) NO317163B1 (de)
NZ (1) NZ335153A (de)
OA (1) OA11038A (de)
PA (1) PA8441101A1 (de)
PE (1) PE10099A1 (de)
PL (1) PL190349B1 (de)
PT (1) PT941100E (de)
SI (1) SI0941100T1 (de)
SK (1) SK284286B6 (de)
SV (1) SV1997000090A (de)
TR (1) TR199900950T2 (de)
UA (1) UA64725C2 (de)
UY (1) UY24766A1 (de)
WO (1) WO1998018477A2 (de)
YU (1) YU19999A (de)
ZA (1) ZA979726B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
CZ20041117A3 (cs) * 2002-04-23 2005-04-13 Lupin Limited Dlouhodobě působící kompozice zahrnující zidovudin a lamivudin
WO2004043433A2 (en) * 2002-11-08 2004-05-27 Glaxo Group Limited Pharmaceutical antiviral compositions
US20040224916A1 (en) 2003-01-14 2004-11-11 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
AR045841A1 (es) * 2004-09-28 2005-11-16 Richmond Sa Com Ind Y Financie Una composicion farmaceutica solida que comprende al tiazolil metil ester del acido [5s-(5r*, 8r*, 10r*,11r*)] -10- hidroxi-2- metil-5-(1-metiletil)-1-[2-(1-metiletil)-4-tiazolil]-3,6-dioxo-8,11-bis(fenilmetil)-2,4,7,12- tetraazatridecan-13-oico y un procedimiento para prepararla.
US20130115237A1 (en) 2010-06-09 2013-05-09 Vaccine Technologies, Incorporated Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment
AU2013229274A1 (en) 2012-03-05 2014-09-04 Cipla Limited Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine
US20140234415A1 (en) * 2013-02-20 2014-08-21 Abbvie Inc. Tablet Dosage Forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
WO1992020344A1 (en) * 1991-05-16 1992-11-26 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
GB9110624D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Combinations
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
WO1998018477A3 (en) 1998-06-18
UY24766A1 (es) 2000-12-29
OA11038A (en) 2002-02-06
EE03806B1 (et) 2002-08-15
BG103435A (en) 2000-04-28
GT199700116A (es) 1999-04-22
IL129422A0 (en) 2000-02-17
KR100551652B1 (ko) 2006-02-13
TR199900950T2 (xx) 1999-07-21
EP0941100A2 (de) 1999-09-15
CY2485B1 (en) 2005-06-03
YU19999A (sh) 2000-10-30
BG64541B1 (bg) 2005-07-29
PE10099A1 (es) 1999-03-02
CA2270174A1 (en) 1998-05-07
EA002437B1 (ru) 2002-04-25
HU224969B1 (en) 2006-04-28
HK1020880A1 (en) 2000-05-26
HRP970569A2 (en) 1998-08-31
KR20000052893A (ko) 2000-08-25
ZA979726B (en) 1999-04-29
NO992091L (no) 1999-06-29
ATE241364T1 (de) 2003-06-15
HRP970569B1 (en) 2004-10-31
DE69722433T2 (de) 2004-04-08
BR9712614A (pt) 1999-10-26
AP1067A (en) 2002-05-01
SK57599A3 (en) 2000-06-12
GEP20022735B (en) 2002-07-25
AU736607B2 (en) 2001-08-02
WO1998018477A2 (en) 1998-05-07
JP2001502718A (ja) 2001-02-27
PL190349B1 (pl) 2005-11-30
PL333143A1 (en) 1999-11-22
IS5024A (is) 1999-04-09
UA64725C2 (uk) 2004-03-15
SV1997000090A (es) 1998-10-07
MY119513A (en) 2005-06-30
EA199900345A1 (ru) 2000-02-28
ES2200204T3 (es) 2004-03-01
SK284286B6 (sk) 2005-01-03
EE9900175A (et) 1999-12-15
NZ335153A (en) 2001-04-27
PT941100E (pt) 2003-10-31
PA8441101A1 (es) 2000-05-24
AP9901519A0 (en) 1999-06-30
AU5314298A (en) 1998-05-22
ID18698A (id) 1998-04-30
CZ296080B6 (cs) 2006-01-11
AR009135A1 (es) 2000-03-08
NO992091D0 (no) 1999-04-29
NO317163B1 (no) 2004-08-30
GB9622681D0 (en) 1997-01-08
SI0941100T1 (en) 2003-12-31
DK0941100T3 (da) 2003-09-01
HUP0000344A2 (hu) 2001-05-28
CO4930269A1 (es) 2000-06-27
HUP0000344A3 (en) 2002-04-29
EP0941100B1 (de) 2003-05-28
CZ155799A3 (cs) 1999-10-13

Similar Documents

Publication Publication Date Title
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
DE122005000024I1 (de) Darifenacin enthaltende Pharmazeutische Zubereitungen.
NO305952B1 (no) 1,5-benzodiazepinderivater, anvendelse derav og farmasoeytiske preparater
NO308298B1 (no) Substituerte kinazolinderivater, anvendelse derav og farmasøytiske preparater inneholdende dem
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
NO307925B1 (no) Bicykliske aromatiske forbindelser, anvendelse derav, og farmasøytiske og kosmetiske preparater
DE59509233D1 (de) Kosmetische und dermatologische zubereitungen, enthaltend phenylen-1,4-bisbenzimidiazolesulfonsäuren
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
ZA985618B (en) Sulfonamide compounds and pharmaceutical use thereof
HUP0103793A3 (en) N-(2-aryl-propionyl)-sulfonamids, their use and pharmaceutical preparations containing them
DE69525148D1 (de) Pharmazeutische formulierung
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
ATE288419T1 (de) Alpha-aryl-n-alkylnitrone sowie diese enthaltende pharmazeutische zubereitungen
DE59704397D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
DE59813619D1 (de) Ascorbinsäurederivate enthaltende kosmetische und pharmazeutische Zubereitungen
DE59607535D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
DE69732649D1 (de) Heteroarylsulfonamidderivate und diese enthaltende pharmazeutische zubereitungen
NO965102D0 (no) Bicykliske aromatiske forbindelser, anvendelser derav, og farmasöytiske og kosmetiske preparater
PT1071433E (pt) 2',2'-difluoronuecleosidos para terapia imunossupressora e preparados farmaceuticos combinados
DE69519368D1 (de) Neue antiandrogenen mitteln pharmazeutische präparate und verwendungen davon
DE69722433D1 (de) Pharmazeutische zubereitungen, welche zidovudin und lamivudine enthalten
DE69705628D1 (de) Chlorfluorkohlenwasserstoff freie aerosol-arzneizubereitungen enthaltend mometasonfuroat
DE59505714D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
ATE281166T1 (de) Tizoxanide und/oder nitazoxanide enthaltende pharmazeutische zubereitungen
NO995838D0 (no) Nye heteroetynylenforbindelser og farmasöytiske og kosmetiske preparater inneholdende de samme

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8330 Complete renunciation